作者：
Eric W F W,Alton [1]
;
Jeffery M,Beekman [2]
;
A Christopher,Boyd [3]
;
June,Brand [4]
;
Marianne S,Carlon [2]
;
Mary M,Connolly [4]
;
Mario,Chan [5]
;
Sinead,Conlon [6]
;
Heather E,Davidson [2]
;
Jane C,Davies [7]
;
Lee A,Davies [1]
;
Johanna F,Dekkers [2]
;
Ann,Doherty [1]
;
Sabrina,Gea-Sorli [2]
;
Deborah R,Gill [2]
;
Uta,Griesenbach [4]
;
Mamoru,Hasegawa [1]
;
Tracy E,Higgins [2]
;
Takashi,Hironaka [2]
;
Laura,Hyndman [7]
;
Gerry,McLachlan [3]
;
Makoto,Inoue [2]
;
Stephen C,Hyde [4]
;
J Alastair,Innes [1]
;
Toby M,Maher [2]
;
Caroline,Moran [2]
;
Cuixiang,Meng [7]
;
Michael C,Paul-Smith [1]
;
Ian A,Pringle [2]
;
Kamila M,Pytel [8]
;
Andrea,Rodriguez-Martinez [1]
;
Alexander C,Schmidt [2]
;
Barbara J,Stevenson [8]
;
Stephanie G,Sumner-Jones [2]
;
Richard,Toshner [4]
;
Shu,Tsugumine [2]
;
Marguerite W,Wasowicz [9]
;
Jie,Zhu [8]
作者单位：
Department of Gene Therapy, National Heart and Lung Institute, Imperial College London, London, UK.
[1]
UK Cystic Fibrosis Gene Therapy Consortium, Oxford, UK.
[2]
Department of Pediatric Pulmonology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Centre, Utrecht, The Netherlands.
[3]
Centre for Genomic and Experimental Medicine, IGMM, University of Edinburgh, Edinburgh, UK.
[4]
Lung Pathology Unit, Department of Airway Disease Infection, NHLI, Imperial College London, London, UK.
[5]
Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Brussels, Belgium.
[6]
Gene Medicine Research Group, NDCLS, John Radcliffe Hospital, Oxford, UK.
[7]
ID Pharme Co. Ltd. (DNAVEC Center), Tsukuba, Japan.
[8]
Roslin Institute & R(D)SVS, University of Edinburgh, Midlothian, UK.
[9]
Fibrosis Research Group, Inflammation, Repair & Development Section, National Heart and Lung Institute, Sir Alexander Fleming Building, Imperial College, London, UK.
[10]
Ave Leopold Wiener, Brussels, Belgium.
[11]
DOI
10.1136/thoraxjnl-2016-208406
PMID
27852956
发布时间
2022-01-29
换一批
换一批
